Clinical Trial Update: Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions [Phase 3]

View source ↗

Summary

A Phase 3 bioequivalence study comparing test and reference testosterone topical gel 1.62% in hypogonadal men has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Hypogonadotropic Hypogonadism

Drugs mentioned

• Testosterone Topical Gel 1.62% (Reference) (testosterone topical gel)
• Testosterone Topical Gel 1.62% (Test) (testosterone topical gel)

Snippet

Sponsor: Amneal Pharmaceuticals, LLC | Conditions: Primary Hypogonadism, Hypogonadotropic Hypogonadism | Phase 3 | Status: COMPLETED